Sanofi-Aventis SA
EPA:EPA:SAN ISIN:FR0000120578
Sanofi-Aventis (EPA:SAN) is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The Company’s business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur. The Company is also present in animal health products through Merial Limited (Merial).
News
Compliance, governance and the impact of regulatory change are just some of the issues that will no doubt be on the agenda at the CFO Summit Europe 2011, which takes place from 13-15 September at The Oitavos, Cascais in Portugal. This closed-door summit, hosted by GDS International, features some of the leading voices in the European CFO sector, including Ramon Zapata, Head of Finance Operations at Novartis (NYSE:NVS); Olivier Klaric, VP Treasury at Sanofi Aventis Group (NYSE:SNY); Erik Ter Horst, CFO EMEA and VP of Finance for BT (NYSE:BT); and Clive Parrit, Vice President of the Institute of Chartered Accountants.
###
4,673 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 19) (Since Published: 4673)
